IDIAClinical Trials•globenewswire•
Idorsia shares new analyses of daridorexant for patients with insomnia at World Sleep 2025
Sentiment:Positive (70)
Summary
(IDIA) Allschwil, Switzerland – September 10, 2025 Idorsia Ltd (SIX: IDIA) shares new analyses of daridorexant for patients with insomnia and further characterizes insomnia disorder at World Sleep 2025, delivering on its ongoing commitment to further the science of sleep and insomnia.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 10, 2025 by globenewswire